VHCP Management II, LLC
New York, NY · CIK 1602263 · 13F filing filed 2020-02-13
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyNew York, NY
$379.4m
reported value
20positions
94.1%in top 10
—no comparable previous quarter
Holdings, Q4 2019
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| 10X GENOMICS INC TXG | $136.2m35.91% | — |
| AXSOME THERAPEUTICS INC AXSM | $81.2m21.42% | — |
| CONSTELLATION PHARMCETICLS I CNST | $70.7m18.64% | — |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $25.2m6.64% | — |
| SHOCKWAVE MED INC SWAV | $12.7m3.34% | — |
| IVERIC BIO INC OPHT | $8.6m2.27% | — |
| KALVISTA PHARMACEUTICALS INC KALV | $6.5m1.72% | — |
| OBSEVA SA COM | $6.0m1.58% | — |
| MERSANA THERAPEUTICS INC COM | $5.3m1.39% | — |
| SPERO THERAPEUTICS INC SPRO | $4.6m1.20% | — |
| RELMADA THERAPEUTICS INC RLMD | $4.5m1.18% | — |
| ADVERUM BIOTECHNOLOGIES INC COM | $4.4m1.16% | — |
| MARINUS PHARMACEUTICALS INC MRNS | $3.2m0.85% | — |
| FORTY SEVEN INC FTSV | $3.1m0.81% | — |
| MILESTONE PHARMACEUTICALS IN MIST | $2.4m0.63% | — |
| NEXTCURE INC COM | $2.0m0.54% | — |
| MYOVANT SCIENCES LTD MYOV | $1.2m0.31% | — |
| 89BIO INC ETNB | $1.1m0.29% | — |
| BELLEROPHON THERAPEUTICS INC BLPH | $230.0k0.06% | — |
| PROTAGONIST THERAPEUTICS INC PTGX | $227.0k0.06% | — |